Affordable Ozempic treatment to launch in South Africa next week
A new, more affordable version of the medication semaglutide is set to arrive in South Africa next week. This treatment is part of a group of medicines known as GLP-1 receptor agonists. It is primarily used by doctors to help patients manage type 2 diabetes effectively.
Semaglutide works by mimicking hormones in the body that regulate blood sugar levels. By helping the body produce insulin when needed, it plays a critical role in the daily health management of many people living with diabetes.
While the medication is widely known for its medical benefits, its availability has been a topic of global discussion. The introduction of this more affordable option is expected to make the treatment accessible to a wider range of patients across the country who rely on it for their long-term health.
Health experts advise that patients should always consult with their doctors before starting or changing any medication. As the launch approaches, medical professionals are preparing to assist patients with questions regarding the new supply and how it fits into their existing treatment plans.